Best Tech Stocks To Watch Right Now

At the height of the dot-com bubble, the Lycos search engine was worth about $240 per eyeball.   About 20 years ago, Internet evangelists argued that profits or even revenue no longer mattered… They created alternative valuations to measure Internet stocks, including the number of "eyeballs" they could attract.   Tech stocks soared. Bulls argued, "This time it's different."   Of course, we know it wasn't. Profits still mattered. And the tech darlings came crashing down – bringing the rest of the market with them. Today, Lycos is worth practically nothing.   "This time it's different" has become a pejorative phrase. It's used by value-investing adherents to tag those willing to buy stocks at anything higher than a reasonable valuation.   So with stocks on the rise… is it different this time?  

Best Tech Stocks To Watch Right Now: Atlantic Coast Federal Corporation(ACFC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Atlantic Coast Financial (NASDAQ: ACFC) and People’s United Financial (NASDAQ:PBCT) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, risk and dividends.

Best Tech Stocks To Watch Right Now: Garrison Capital Inc.(GARS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Garrison Capital (GARS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Garrison Capital (GARS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Garrison Capital (NASDAQ:GARS)‘s stock had its “buy” rating restated by stock analysts at National Securities in a research report issued on Monday. They currently have a $10.00 target price on the investment management company’s stock. National Securities’ price objective would indicate a potential upside of 18.91% from the stock’s current price.

  • [By Joseph Griffin]

    Garrison Capital (NASDAQ: GARS) and Amern Cap Sr Fl/COM (NASDAQ:ACSF) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability.

  • [By Shane Hupp]

    Garrison Capital (NASDAQ:GARS) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday.

  • [By Shane Hupp]

    Garrison Capital (NASDAQ: GARS) and PennantPark Investment (NASDAQ:PNNT) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability.

Best Tech Stocks To Watch Right Now: Medical Marijuana, Inc. (MJNA)

Advisors’ Opinion:

  • [By Keith Speights]

    Marijuana grower

    Canopy Growth Corporation (NYSE:CGC) $5.8 billion
      Aurora Cannabis (NASDAQOTH: ACBFF) $2.9 billion
      Tilray (NASDAQ: TLRY) $2.3 billion
      Aphria (NASDAQOTH: APHQF) $1.9 billion
      MedMen Enterprises (NASDAQOTH: MMNFF) $1.3 billion
      Cronos Group (NASDAQ: CRON) $1 billion
      The Green Organic Dutchman (NASDAQOTH: TGODF) $1 billion
      The Hydropothecary (NASDAQOTH: HYYDF) $728 million
      CannTrust Holdings (NASDAQOTH: CNTTF) $513 million
      Organigram Holdings (NASDAQOTH: OGRMF) $509 million
      Marimed (NASDAQOTH: MRMD) $472 million
      TerrAscend (NASDAQOTH: TRSSF) $398 million
      Auxly Cannabis (NASDAQOTH: CBWTF) $368 million
      iAnthus Capital Holdings (NASDAQOTH: ITHUF) $367 million
      Medical Marijuana (NASDAQOTH: MJNA) $330 million
      CV Sciences (NASDAQOTH: CVSI) $299 million
      Emerald Health Therapeutics (NASDAQOTH: EMHTF) $287 million
      Supreme Cannabis (NASDAQOTH: SPRWF) $277 million
      Smart Cannabis (NASDAQOTH: SCNA) $276 million
      MPX Bioceutical (NASDAQOTH: MPXEF) $234 million
      AusCann Group Holdings (NASDAQOTH: ACNNF) $223 million
      Liberty Health Sciences (NASDAQOTH: LHSIF) $213 million

    Biotech

  • [By Keith Speights]

    Marijuana grower

    Canopy Growth Corporation (NYSE:CGC) $5.8 billion
      Aurora Cannabis (NASDAQOTH: ACBFF) $2.9 billion
      Tilray (NASDAQ: TLRY) $2.3 billion
      Aphria (NASDAQOTH: APHQF) $1.9 billion
      MedMen Enterprises (NASDAQOTH: MMNFF) $1.3 billion
      Cronos Group (NASDAQ: CRON) $1 billion
      The Green Organic Dutchman (NASDAQOTH: TGODF) $1 billion
      The Hydropothecary (NASDAQOTH: HYYDF) $728 million
      CannTrust Holdings (NASDAQOTH: CNTTF) $513 million
      Organigram Holdings (NASDAQOTH: OGRMF) $509 million
      Marimed (NASDAQOTH: MRMD) $472 million
      TerrAscend (NASDAQOTH: TRSSF) $398 million
      Auxly Cannabis (NASDAQOTH: CBWTF) $368 million
      iAnthus Capital Holdings (NASDAQOTH: ITHUF) $367 million
      Medical Marijuana (NASDAQOTH: MJNA) $330 million
      CV Sciences (NASDAQOTH: CVSI) $299 million
      Emerald Health Therapeutics (NASDAQOTH: EMHTF) $287 million
      Supreme Cannabis (NASDAQOTH: SPRWF) $277 million
      Smart Cannabis (NASDAQOTH: SCNA) $276 million
      MPX Bioceutical (NASDAQOTH: MPXEF) $234 million
      AusCann Group Holdings (NASDAQOTH: ACNNF) $223 million
      Liberty Health Sciences (NASDAQOTH: LHSIF) $213 million

    Biotech

  • [By George Budwell]

    Medical Marijuana (NASDAQOTH:MJNA) is only a matter of months away from its 10-year anniversary as the first publicly traded cannabis stock. Despite its elder-statesman status, however, Medical Marijuana hasn’t been kind to investors since going public. In fact, the stock is down by nearly 90% since its IPO in March of 2009.

  • [By Javier Hasse]

    Medical Marijuana Inc (OTC: MJNA) announced Q1 2018 as its largest sales revenue quarter in company history with a year-over-year gross revenue increase of 191 percent. Revenue exceeded $10.5 million. The company also announced its subsidiary Kannaway has partnered with Christian Okoye, former all-time rushing leader for the Kansas City Chiefs, to speak out on why the NFL should consider allowing its players to take cannabidiol (CBD). He’s stopped taking all pain medications and is now only taking CBD.

  • [By Sean Williams]

    If I were to choose two marijuana stocks right off the bat that I’d rather watch from the sidelines and never buy, it’d be medical cannabis company Medical Marijuana Inc. (NASDAQOTH:MJNA) and cannabinoid-based drug developer AXIM Biotechnologies (NASDAQOTH:AXIM). The reason they’re listed together is because Medical Marijuana Inc. owns 22.67 million shares of AXIM, which is about 40% of its outstanding share count. Their futures really are tied together.

  • [By Keith Speights]

    Two stocks that hope to become big winners in this hemp market are Medical Marijuana (NASDAQOTH:MJNA) and CV Sciences (NASDAQOTH:CVSI). CV Sciences has performed a lot better than Medical Marijuana has, with its share price skyrocketing nearly 600% last year compared with Medical Marijuana’s 50% plunge. But which of these stocks is the better pick now?

Leave a Reply

Your email address will not be published. Required fields are marked *